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Abstract Among oxysterols oxidized at C7 (7K-, 7L-hydroxy-
cholesterol, and 7-ketocholesterol), 7L-hydroxycholesterol and
7-ketocholesterol involved in the cytotoxicity of oxidized low
density lipoproteins (LDL) are potent inducers of apoptosis.
Here, we asked whether all oxysterols oxidized at C7 were able
to trigger apoptosis, to stimulate interleukin (IL)-1L and/or
tumor necrosis factor (TNF)-K secretion, and to enhance
adhesion molecule expression (intercellular adhesion molecule-1
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-
selectin) on human umbilical venous endothelial cells (HUVECs).
Only 7L-hydroxycholesterol and 7-ketocholesterol were potent
inducers of apoptosis and of IL-1L secretion. TNF-K secretion
was never detected. Depending on the oxysterol considered,
various levels of ICAM-1, VCAM-1 and E-selectin expression
were observed. So, oxysterols oxidized at C7 differently injure
and activate HUVECs, and the K- or L-hydroxyl radical position
plays a key role in apoptosis and IL-1L secretion.
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1. Introduction
It is now well established that early events occurring in the
pathogenesis of atherosclerosis include oxidation of low den-
sity lipoproteins (LDL), accumulation of oxidized LDL
(LDLox) at the sub-endothelial level [1], extravasation of leu-
kocytes such as monocytes or lymphocytes [2,3] and accumu-
lation of LDLox in tissue monocytes/macrophages to form
foam cells that pile up in the atherosclerotic lesion [4]. It
has also been demonstrated that LDLox are strongly cyto-
toxic on cultured endothelial cells [5], and that they induce
on these cells massive apoptosis [6] as well as adhesion mol-
ecule expression [7,8] such as vascular cell adhesion molecule-
1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1),
and E-selectin which are overexpressed on endothelial cells
from hypercholesterolemic fed rabbits and from hypercholes-
terolemic patients [9,10], and which also play a major role in
extravasation of monocytes and lymphocytes recruited during
the atherosclerotic process [11]. Since LDLox are a complex
mixture of lipid hydroperoxides, aldehydes, and oxysterols [4]
it remains to be determined what components can mimic the
various e¡ects of LDLox at the endothelial level.
To date, it is well known that oxysterols which are a family
of molecules resulting either from peroxidation of cholesterol
[12], from enzyme-catalyzed transformation [13] or from auto-
oxidation of cholesterol in air [14], have a wide range of bio-
logical activities similar to those of LDLox [15^17].
Particularly, aorta of rabbits fed with concentrated oxyster-
ols exhibit di¡use ¢brous lesions [18]; toxic e¡ects of oxyster-
ols have also been identi¢ed in cultured endothelial cells [19],
and we have demonstrated in our laboratory that 7L-hydroxy-
cholesterol and 7-ketocholesterol induced apoptosis in bovine
aortic endothelial cells [20]. Similar features of cell death were
also observed on human umbilical venous endothelial cells
(HUVECs) treated with 7-ketocholesterol [21] or with 7L-hy-
droxycholesterol [22]. It has also been reported that the hu-
man promonocytic leukemia cells U937 incubated with 7L-
hydroxycholesterol and 7-ketocholesterol released interleukin
(IL)-1L in the culture medium [23]. However, up to now, the
cytotoxic e¡ects of 7K-hydroxycholesterol have not been
studied.
Since processing and release of IL-1L and/or of tumor ne-
crosis factor (TNF)-K (known to modulate adhesion molecule
expression involved in the extravasation of immunocompetent
cells [8]) can occur during the apoptotic process [23,24], we
investigated in the present work whether all oxysterols oxi-
dized at C7 (7K-, 7L-hydroxycholesterol, and 7-ketocholester-
ol) were able to induce apoptosis, to stimulate IL-1L and/or
TNF-K secretion, and to enhance the expression of adhesion
molecules (i.e. ICAM-1, VCAM-1 and E-selectin) involved in
the recruitment of immunocompetent cells especially at the
early stages of atherosclerosis [4].
2. Materials and methods
2.1. Cultures of human umbilical venous endothelial cells (HUVECs)
HUVECs were obtained from umbilical cord veins as previously
described [25]. HUVECs were seeded at 2.5U106 cells in 75-cm2 tissue
culture £asks (Falcon/Becton-Dickinson, Plymouth, UK) containing
15 ml of culture medium consisting of medium 199 with Earle’s salts,
2.2 g/l NaHCO3, amino acids and Glutamax I (Gibco, Eragny,
France), supplemented with antibiotics (10 U/ml penicillin, 10 Wg/ml
streptomycin) (Gibco), and 20% heat-inactivated fetal calf serum
(Boehringer-Mannheim, Meylan, France). At con£uence, HUVECs
were treated with a solution of 0.05% trypsin/0.02% EDTA (Gibco).
At the ¢rst passage and further, they were cultured in the above
growth medium plus 100 Wg/ml endothelial cell growth supplement
(Sigma) and 90 Wg/ml heparin (Sigma) [26]. HUVECs were grown
at 37‡C in a humidi¢ed atmosphere containing 5% CO2, and all sub-
sequent experiments were done at the second passage. To check that
HUVECs were used in a non-proliferating state, analysis of cell prolif-
eration was performed by £ow cytometry [27], and for all experiments,
at least 80% of the cells were in the G0/G1 phase of the cell cycle.
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2.2. Cell treatments
7K- and 7L-hydroxycholesterol were purchased from Steraloids
(Wilton, USA), and 7-ketocholesterol was provided by Sigma-Aldrich
(L’Isle d’Abeau-Chesnes, France). The purity of oxysterols deter-
mined by CPG/GSM was 100%. 7K-, 7L-hydroxycholesterol, and 7-
ketocholesterol solutions were prepared as previously described
[20,21,23], and used at 10, 20, and 40 Wg/ml ¢nal concentrations.
Treatments with oxysterols were performed either for 20 or 48 h on
con£uent non-proliferating HUVECs.
2.3. Quantitative determination of internucleosomal DNA
fragmentation by ELISA
DNA fragmentation analysis was carried out by a photometric
enzyme immunoassay for the quantitative and qualitative in vitro
determination of cytoplasmic histone-associated DNA fragments
with the cell death detection ELISAplus kit (Boehringer-Mannheim,
Meylan, France) according to the manufacturer’s protocol. Data
were expressed by the ratio: enzyme activity in treated cells/enzyme
activity in untreated cells (% control) [28]. All assays were performed
at least in triplicate, and the absorbance was read on a Biomek 2000
(Beckman, Palo Alto, CA, USA) at 405 nm.
2.4. Nuclear staining with Hoechst 33342
Nuclear morphology of control and treated cells was studied after
staining with Hoechst 33342 (Sigma, St. Louis, MO, USA) as previ-
ously described [20,21]. Apoptotic cells were characterized by con-
densed and/or fragmented nuclei [29]. The morphological aspect of
nuclei was observed with an inverted Laborlux IX70 microscope
(Olympus, Tokyo, Japan) by using UV light excitation, and 300 cells
were examined per sample.
2.5. In situ detection of DNA fragmentation
In situ visualization of DNA fragmentation at the single cell level
was performed by the TdT-mediated dUTP-biotin nick end-labelling
method (TUNEL method) developed by Gavrieli et al. [30] by using
the MEBSTAIN apoptosis kit (Immunotech, Marseille, France) ac-
cording to the manufacturer’s procedure. The signal of TdT-mediated
dUTP-biotin nick end-labelling was detected by incubation for 30 min
at room temperature with peroxidase-conjugated streptavidin (Dako,
Copenhagen, Denmark) diluted 1:300 in PBS/0.2% BSA, and deter-
mination of peroxidase activity was performed with 3,3P-diaminoben-
zidine using the Dako Liquid DAB Substrate Chromogen System
(Dako). HUVECs were counterstained with methylene blue (RAL/
RhoŒne-Poulenc, Villers Saint-Paul, France). The slides were mounted
in Fluoprep (BiomeŁrieux, Marcy l’Etoile, France), coverslipped, and
stored in the dark at 4‡C. Observations were made with an inverted
Laborlux IX70 microscope (Olympus).
2.6. Analysis of IL-1L and TNF-K by ELISA
To determine the secretion level of IL-1L and TNF-K, control and
treated HUVECs were used. Brie£y, the cells were seeded at 25 000
cells per well of 96-well plates (Falcon/Becton-Dickinson) containing
120 Wl of culture medium, and 7K-, 7L-hydroxycholesterols and 7-
ketocholesterol were then introduced in the culture medium at 10,
20 or 40 Wg/ml. After 20 h of treatment, the culture medium of control
and treated cells was collected by centrifugation, and the cells present
in the pellet were counted after resuspension in PBS. IL-1L and TNF-
K concentrations in the culture medium were measured according to
the manufacturer’s procedure with high sensitivity ELISA kits Quan-
tikines H.S. (RpD, Abingdon, UK) which allows a detection level as
low as 0.125 pg/ml of IL-1L, and 0.5 pg/ml of TNF-K. All assays were
performed at least in triplicate, the absorbance was read at 490 nm on
a Biomek 2000 (Beckman, Palo Alto, CA, USA), and the data were
expressed in pg of IL-1L or TNF-K per 106 cells.
2.7. Quanti¢cation of cell adhesion molecules (VCAM-1, ICAM-1, and
E-selectin) by ELISA
To quantify adhesion molecule expression, control and treated HU-
VECs were used. Brie£y, the cells were seeded at 25 000 cells per well
of 96-well plates (Falcon/Becton-Dickinson) containing 120 Wl of cul-
ture medium, and 7K-, 7L-hydroxycholesterols and 7-ketocholesterol
were then introduced in the culture medium at 10, 20 or 40 Wg/ml.
After 20 h of treatment, the culture medium of control and treated
cells was collected by centrifugation, the cells were washed twice in
PBS, and the primary antibodies (mouse anti-human VCAM-1, mouse
anti-human ICAM-1, or mouse anti-human E-selectin from RpD,
Abingdon, UK) were added to each well, and incubated for 1 h at
4‡C (50 Wl per microwell of a 10 Wg/ml primary antibody solution
diluted in PBS/1% BSA/0.01% NaN3). At the end of the incubation
period, the cells were washed 4 times with PBS/1% BSA, and then
incubated for 1 h at 4‡C with a peroxidase conjugated goat anti-
mouse IgG (Bio-Rad Laboratories, Richmond, CA, USA) diluted
1:500 in PBS/1% BSA. The microwells were further washed 4 times
with PBS, and the enzymatic activity was detected by the addition of
100 Wl of a orthophenylenediamine solution (0.4 mg/ml) containing
0.002% hydrogen peroxide. After 15 min of incubation at room tem-
perature, the reaction was stopped by addition of 50 Wl of H2SO4
(2N). All assays were performed at least in triplicate, and the absorb-
ance was read on a Biomek 2000 (Beckman, Palo Alto, CA, USA) at
490 nm. Cells only stained with the peroxidase-conjugated goat anti-
mouse IgG were used as a conjugated control. To estimate the in-
volvement of IL-1L secretion in adhesion molecules expression, con-
trol HUVECs were treated with various concentrations of recombi-
nant IL-1L (RpD, Abingdon, UK): 200, 2000 and 20 000 pg of
recombinant IL-1L for 106 cells.
2.8. Statistical methods
Statistical analyses were performed with SYSTAT software (Evan-
ston, IL, USA) by using a one-way analysis of variance (ANOVA)
followed by a Dunett t-test.
3. Results
3.1. Induction of apoptosis by oxysterols oxidized at C7
position
The mode of cell death, apoptosis vs. necrosis, induced on
HUVECs treated with 7K-, 7L-hydroxycholesterol or 7-keto-
cholesterol for 20 and 48 h was de¢ned with biochemical and
morphological criteria. Whatever the time of treatment, expo-
sure of HUVECs to 7K-hydroxycholesterol (10, 20 and 40 Wg/
ml) did not induce internucleosomal DNA fragmentation
quanti¢ed by ELISA (Fig. 1), and the morphological aspect
of 7K-hydroxycholesterol-treated cell nuclei observed after
staining with Hoechst 33342 was the same as those of un-
treated cells (Fig. 2A). Similarly, when HUVECs were incu-
bated with 7-ketocholesterol (10, 20 Wg/ml) or 7L-hydroxy-
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Fig. 1. E¡ects of oxysterols oxidized at C7 on DNA fragmentation.
HUVECs were treated for 20 and 48 h with 10, 20 or 40 Wg/ml of
7K-hydroxycholesterol (7K), 7L-hydroxycholesterol (7L) and 7-keto-
cholesterol (7keto), and DNA fragmentation was determined by a
quantitative determination of internucleosomal DNA fragmentation
by ELISA. Values are means þ S.E.M. and re£ect 3 separate experi-
ments, each performed in triplicate. ** and * indicate the values dif-
ferent (P6 0.01 and P6 0.05, respectively) from control.
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cholesterol (10 Wg/ml) no internucleosomal DNA fragmenta-
tion (Fig. 1) and no morphological changes of the nuclei were
observed. In contrast, as early as after 20 h of treatment, 7L-
hydroxycholesterol (20 and 40 Wg/ml) and 7-ketocholesterol
(40 Wg/ml) were potent inducers of DNA fragmentation
known to occur during apoptosis (Fig. 1), but the highest
percentages of DNA fragmentation were observed at 48 h.
Cell death by apoptosis was con¢rmed by nuclei staining
with Hoechst 33342, and by the in situ detection of DNA
fragmentation with the TUNEL method. Thus, as compared
with untreated HUVECs exhibiting regular nuclei (Fig. 2A),
7L-hydroxycholesterol (20 and 40 Wg/ml) and 7-ketocholester-
ol (40 Wg/ml) induced apoptotic cells characterized by con-
densed and/or fragmented nuclei after Hoechst staining (Fig.
2B), and the TUNEL method revealed the presence of frag-
mented DNA in some condensed and/or fragmented nuclei
(Fig. 2D) whereas no DNA fragmentation was found in un-
treated cells (Fig. 2C). According to these data, further experi-
ments related to IL-L and TNF-K secretion, as well as to
adhesion molecule expression, were performed at 20 h of
treatment to de¢ne the e¡ects of oxysterols at an early time
of the apoptotic process.
3.2. E¡ects of 7K-, 7L-hydroxycholesterol and 7-ketocholesterol
on the secretion of IL-1L and TNF-K
To investigate the possibility of cytokine release in oxyster-
ol-treated endothelial cells, we measured the secretion of
TNF-K and IL-1L in the supernatants of HUVECs incubated
either with 7K-, 7L-hydroxycholesterol or 7-ketocholesterol
(10, 20 or 40 Wg/ml) for 20 h. No secretion of TNF-K was
detected for any of the oxysterols considered, and with 7K-
hydroxycholesterol a slight but not signi¢cant increase of IL-
1L was found (Fig. 3). However, when compared to untreated
HUVECs, IL-1L production was signi¢cantly higher in endo-
thelial cells treated with 7-ketocholesterol (20 and 40 Wg/ml),
and the most important e¡ects were obtained with 7L-hydroxy-
cholesterol which induced a 30-fold increase of IL-1L secre-
tion at 40 Wg/ml and a 10-fold increase at 20 Wg/ml (Fig. 3).
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Fig. 2. Morphological characterization of cell death by nuclear staining with Hoechst 33342 and by the TUNEL method. HUVECs treated for
20 or 48 h with 7K-, 7L-hydroxycholesterol and 7-ketocholesterol used at 10, 20 or 40 Wg/ml were characterized by £uorescence microscopy
after nuclear staining with Hoechst 33342, and by bright¢eld microscopy after in situ identi¢cation of internucleosomal DNA fragmentation
with the TUNEL method. Fluorescence microscopy of untreated HUVECs (A), and of HUVECs treated for 48 h with 7-ketocholesterol (40
Wg/ml) (B) (apoptotic cells with condensed and/or fragmented nuclei are observed). Bright¢eld microscopy of untreated HUVECs (C) and of
HUVECs treated for 20 h with 40 Wg/ml of 7L-hydroxycholesterol (D) (the fragmented DNA revealed by the TUNEL method in the nuclei of
apoptotic cells is colored in brown; it is only detected in treated cells). Scale bar = 5 Wm.
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3.3. E¡ects of 7K-, 7L-hydroxycholesterol and 7-ketocholesterol
on ICAM-1, VCAM-1 and E-selectin expression
To de¢ne whether oxysterols oxidized at C7 position in-
duced the expression of adhesion molecules on the surface
of endothelial cells, HUVECs were treated with 7K-, 7L-hy-
droxycholesterol and 7-ketocholesterol at concentrations of
10, 20 or 40 Wg/ml for 20 h, and the expression of the adhe-
sion molecules ICAM-1, VCAM-1 and E-selectin was meas-
ured using an ELISA assay. The surface expression of ICAM-
1 was increased by oxysterol treatments but varied according
to the oxysterol considered (Fig. 4A). Therefore, 7L-hydroxy-
cholesterol had a stronger e¡ect on ICAM-1 expression than
either 7K-hydroxycholesterol or 7-ketocholesterol. Indeed, a
40-Wg/ml concentration of 7L-hydroxycholesterol induced a
5-fold increase of ICAM-1 expression vs. 3-fold and 1.5-fold
increases with 7K-hydroxycholesterol and 7-ketocholesterol,
respectively. With 10 and 20 Wg/ml, only 7L-hydroxycholester-
ol treated cells exhibited a signi¢cant increase of ICAM-1
expression with 2- and 3.5-fold increases, respectively.
VCAM-1 expression was signi¢cantly induced by all oxyster-
ols at the concentration of 40 Wg/ml (Fig. 4B). However,
VCAM-1 expression was also signi¢cantly increased at a con-
centration of 20 Wg/ml on 7L-hydroxycholesterol-treated cells.
As for E-selectin, all oxysterols induced its expression at 20
and 40 Wg/ml but at levels varying according to the type of
oxysterol considered (Fig. 4C). Therefore, 7L-hydroxycholes-
terol appeared to be the most potent inducer of E-selectin
expression and 7-ketocholesterol the least.
3.4. E¡ects of recombinant IL-1L on ICAM-1, VCAM-1 and
E-selectin expression
To de¢ne whether enhanced IL-1L secretion was su⁄cient
to increase ICAM-1, VCAM-1 and E-selectin expression, HU-
VECs were treated for 20 h with 200, 2000 and 20 000 pg of
recombinant IL-1L per 106 cells. In those conditions, incuba-
tion of HUVECs with recombinant IL-1L did not induce suf-
¢cient expression of ICAM-1, VCAM-1 and E-selectin when
compared to the secretion of IL-1L (around 1^4 pg per 106
cells) found in oxysterol-treated cells. Indeed, at least 2000 pg
of recombinant IL-1L were required to induce similar levels of
VCAM-1 expression compared to those observed in 7L-hy-
droxycholesterol treated HUVECs. In addition, even 20 000
pg of recombinant IL-1L remained insu⁄cient to reach the
ICAM-1 and E-selectin expression levels found especially in
7L-hydroxycholesterol-treated cells. Therefore, IL-1L is cer-
tainly not the only factor controlling adhesion molecule ex-
pression in oxysterol-treated HUVECs.
4. Discussion
The early steps of atherosclerosis need the interaction of
monocytes and T lymphocytes with vascular endothelial cells.
The recruitment of these circulating blood cells is mediated by
speci¢c adhesion molecules such as ICAM-1, VCAM-1 or E-
selectin expressed by activated endothelial cells in a process
analogous to acute or chronic in£ammation [31] where
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Fig. 3. Quanti¢cation of IL-1L secretion in oxysterol-treated HU-
VECs. Cells were incubated for 20 h with 10, 20 or 40 Wg/ml of 7K-
hydroxycholesterol (7K), 7L-hydroxycholesterol (7L) and 7-ketochol-
esterol (7keto), and the supernatants were used to determine IL-1L
secretion. Values are means þ S.E.M. and re£ect 3 separate experi-
ments, each performed in triplicate. ** and * indicate the values dif-
ferent (P6 0.01 and P6 0.05, respectively) from control.
Fig. 4. E¡ect of 7K, 7L-hydroxycholesterol and 7-ketocholesterol on
ICAM-1, VCAM-1 and E-selectin expression. HUVECs were plated
in 96-well plates, and incubated for 20 h with 10, 20 or 40 Wg/ml of
7K-hydroxycholesterol (7K), 7L-hydroxycholesterol (7L) and 7-keto-
cholesterol (7keto). The expression of adhesion molecules ICAM-1
(A), VCAM-1 (B) and E-selectin (C) was determined by ELISA.
Values are means þ S.E.M. and re£ect 3 separate experiments, each
performed in triplicate. ** and * indicate the values di¡erent
(P6 0.01 and P6 0.05, respectively) from control.
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VCAM-1 interacts with very late antigen-4 (VLA-4), which is
a L1 integrin that is di¡erentially expressed on lymphocytes
and monocytes but not on polymorphonuclear leukocytes
[32]. This process requires the release of IL-1L and/or TNF-
K involved in monocyte and lymphocyte recruitment by stim-
ulating the endothelial expression of the adhesion molecules
ICAM-1, VCAM-1, and E-selectin [33]. We hypothesized that
this release of cytokines could be mediated by the endothelial
cells under the action of oxysterols since we have previously
reported on U937 cells that 7L-hydroxycholesterol and 7-ke-
tocholesterol-induced apoptosis was associated with an en-
hanced secretion of IL-1L [23]. Taken together, these di¡erent
observations have led us to consider whether all oxysterols
oxidized at C7 (7K-, 7L-hydroxycholesterol, and 7-ketocholes-
terol) were able to induce apoptosis, to stimulate IL-1L and/or
TNF-K secretion as well as the expression of the adhesion
molecules ICAM-1, VCAM-1, and E-selectin on human um-
bilical venous endothelial cells (HUVECs). In the present
work, we demonstrated on HUVECs that only 7L-hydroxy-
cholesterol and 7-ketocholesterol, but not 7K-hydroxycholes-
terol, were potent inducers of apoptosis and of IL-1L secre-
tion, and that the levels of adhesion molecule expression
(ICAM-1, VCAM-1, and E-selectin) depend on the oxysterol
considered. Noteworthy, an induction of TNF-K secretion
was never observed.
Interestingly, in agreement with previous reports, 7L-hy-
droxycholesterol and at a lower extent 7-ketocholesterol in-
duced apoptosis on endothelial cells [20,21]. However, 7K-hy-
droxycholesterol was not an inducer of apoptosis, and had no
cytotoxic e¡ects (data not shown) when cell death was char-
acterized at 20 and 48 h with criteria previously used to dem-
onstrate the toxicity of oxysterols, i.e. loss of cell adhesion,
and increased permeability to propidium iodide [20,21]. So,
these observations provide new arguments indicating that
7L-hydroxycholesterol and 7-ketocholesterol are able to mimic
the cytotoxic e¡ects of LDLox by inducing apoptosis [20^22]
but they also suggest that the biological e¡ects of oxysterols
oxidized at C7 vary according to the nature of C7 bond, and
that the position (K or L) of the hydroxyl radical plays a
critical role in the induction of the apoptotic process.
As for cytokine secretion, only 7L-hydroxycholesterol and
7-ketocholesterol induced signi¢cant IL-1L secretion, but no
TNF-K secretion was observed either with 7K-, 7L-hydroxy-
cholesterol and 7-ketocholesterol. Noteworthy, early in the
apoptotic process (20 h of treatment), we observed with 7L-
hydroxycholesterol and 7-ketocholesterol (especially at 40 Wg/
ml) a positive correlation between the percentage of DNA
fragmentation (corresponding to the ability of the oxysterol
to induce apoptosis) and the level of IL-1L secretion per cell.
Thus, 7L-hydroxycholesterol and 7-ketocholesterol, which are
potent inducers of apoptosis, induced also the highest levels of
IL-1L secretion whereas only a slight but not signi¢cant secre-
tion of IL-1L was observed under treatment with 7K-hydroxy-
cholesterol which had no cytotoxic e¡ects. As IL-1L is syn-
thesized as a promolecule which is proteolytically processed
by the interleukin-1L-converting enzyme (ICE) belonging to
the cysteinyl aspartate-speci¢c proteinase family (caspases)
which are activated during apoptosis [34], our data lead to
suppose that 7L-hydroxycholesterol and 7-ketocholesterol
could activate the conversion of pro-IL-1L to IL-1L during
cell death. This provides additional arguments indicating
that 7L-hydroxycholesterol and 7-ketocholesterol are able to
mimic, at least in part, the e¡ects of LDLox [35,36]. As
LDLox containing high levels of 7L-hydrocholesterol and of
7-ketocholesterol [37] have also been described to induce
TNF-K secretion on human monocytes/macrophages [38], we
asked whether a similar phenomenon could occur on HU-
VECs treated with oxysterols oxidized at C7. The inability
of 7K-, 7L-hydroxycholesterol and 7-ketocholesterol to induce
the secretion of TNF-K suggests that the expression and/or the
secretion of this cytokine is either under the control of other
compounds present in the LDLox, or depends on the cell type
considered.
The quanti¢cation of ICAM-1, VCAM-1, and E-selectin on
HUVECS treated with oxysterols oxidized at C7 constitutes
the major new ¢nding of this study. Indeed, we report for the
¢rst time that oxysterols can induce adhesion molecule expres-
sion on endothelial cells, and that this phenomenon occurs
early (after 20 h of treatment) during apoptosis. Therefore,
the overexpression of adhesion molecules observed on endo-
thelial cells from hypercholesterolemic subjects [9,10] could be
due to enhanced concentrations of oxysterols present in the
plasma [39], and/or to oxysterol deposits found in the athero-
sclerotic lesions of these patients [40]. It is obvious that 7L-
hydroxycholesterol, which is the most potent inducer of apop-
tosis and of IL-1L secretion, also stimulates the highest level
of adhesion molecule expression (ICAM-1, VCAM-1, and E-
selectin). However, 7-ketocholesterol which also triggered
apoptosis and stimulated IL-1L secretion, induced a lower
expression of adhesion molecule than 7K-hydroxycholesterol
which has no cytotoxic e¡ects. Therefore, on HUVECs
treated with 7K-, 7L-hydroxycholesterol or 7-ketocholesterol
it seems that IL-1L secretion could not be directly related to
adhesion molecules expression in contrast to what has been
previously suggested for macrophages [24] or HUVECs de-
prived of growth factors [41]. This hypothesis is reinforced
by our observations performed with recombinant IL-1L,
which has biological activities similar to the naturally occur-
ring forms of the molecule [42]. Thus, similar levels of
VCAM-1 were obtained only when HUVECs were treated
with high concentrations of recombinant IL-1L, but even at
very high concentrations of recombinant IL-1L the levels of
ICAM-1 and E-selectin were lower than those obtained on 7L-
hydroxycholesterol-treated cells. Therefore, in oxysterol-
treated cells, IL-1L is probably not the only component in-
volved in the expression of ICAM-1, VCAM-1, and E-selec-
tin. As apoptosis of HUVECs induced by growth factor dep-
rivation or mitomycin C is associated with a paracrine
induction of ICAM-1 and VCAM-1 under the action of IL-
1L but also of other unidenti¢ed in£ammatory mediators [41],
it is possible that oxysterol-induced adhesion molecules on
HUVECs could be mediated by a similar manner by some
cytokines secreted during cell death. Indeed, as the percentage
of DNA fragmentation was higher at 48 h of treatment than
at 20 h, this leads us to suggest that some viable cells are still
present at 20 h. Therefore, our data raise the possibility that
mediators released by apoptotic cells may act in a paracrine
fashion to induce adhesion molecule expression by adjacent
viable cells [41].
In conclusion, the biological activities of oxysterols oxidized
at C7 are tightly regulated since the di¡erent e¡ects observed
on HUVECs depend on the radical (hydroxyl or keto) present
at C7, but also on the K or L position of the hydroxyl radical.
According to our observations, 7K-, 7L-hydroxycholesterol
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and 7-ketocholesterol could play a critical role in atheroscle-
rosis by inducing functional and antigenic modi¢cations at the
endothelium level. Thus, by triggering apoptosis of endothe-
lial cells, IL-1L secretion and/or adhesion molecule expression
(ICAM-1, VCAM-1, and E-selectin), oxysterols oxidized at
C7 could not only increase the permeability of the vascular
endothelium to LDL, but also favor the adhesion and extra-
vasation of monocytes and lymphocytes, which are the main
leukocytes found in atheromatous lesions.
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